Rural and Remote Health Journal photo
African section Asian section Australasian section European section International section Latin American section
home
login/register
current articles
contribute
information for authors
status/user profile
links/forums
about us

Short Communication

Challenges of hepatitis C treatment in Native Americans in two North Dakota medical facilities

Submitted: 7 January 2014
Revised: 26 March 2014
Accepted: 8 April 2014
Published: 18 September 2014

Full text: You can view the full article, or view a printable version.
Comments: (login to access the comments on this article)

Author(s) : Hossain S, Jalil S, Guerrero DM, Sahmoun AE.

Citation: Hossain S, Jalil S, Guerrero DM, Sahmoun AE.  Challenges of hepatitis C treatment in Native Americans in two North Dakota medical facilities. Rural and Remote Health (Internet) 2014; 14: 2982. Available: http://www.rrh.org.au/articles/subviewnew.asp?ArticleID=2982 (Accessed 21 October 2017)

ABSTRACT

Introduction:  The prevalence of chronic liver disease (CLD) in the Aboriginal North American population is disproportionately higher than that of the non-indigenous population. Hepatitis C virus (HCV) is the second leading cause of CLD in American Indians or Alaska Natives (AIANs). This study described the experience of two teaching community medical centers in North Dakota in treating HCV infection among AIANs and compared treatment outcomes to a cohort of Caucasian patients.
Methods:  The retrospective study described the characteristics and proportion of AIAN patients with HCV who received treatment. Documented reasons for not receiving treatment were analyzed. For those AIAN patients treated for HCV infection, responses to treatment, including rapid, early and sustained virological responses (SVRs), were compared with those of Caucasians.
Results:  Only 22 (18%) of 124 AIANs with HCV infection received treatment. Common reasons for not receiving treatment include lack of access to specialists, concomitant or decompensated liver disease, alcohol and drug abuse and cost. There were no significant differences in the baseline characteristics and key predictors of SVR in AIANs compared to Caucasian controls.
Conclusions:  Most AIAN patients with HCV infection do not receive treatment despite comparable treatment response rates to Caucasians. Further population-based studies, addressing access to specialized hepatitis C treatment and public health concerns are warranted, as it is crucial to treat chronic HCV infection to decrease the burden of disease in the AIAN community.

Key words: epidemiology, ethnicity, hepatitis C, infectious disease, Native Americans, treatment.

This abstract has been viewed 2406 times since 18-Sep-2014.

   
 

   CONTACT US | COPYRIGHT AND DISCLAIMER | ADMIN ONLY